Advanced Accelerator Applications
At Advanced Accelerator Applications, we are reimagining nuclear medicine and cancer care. Our mission is to transform patients’ lives by developing and delivering targeted radioligand therapies and precision diagnostic solutions for oncology.
Basic Information
- Category: Other
- Founded: 2002
- Website: http://www.adacap.com
Evidence and Sources
- Advanced Accelerator Applications — Official Site (official)
- Advanced Accelerator Applications — Wikipedia (reference)
Citation Guidance
Explore Other profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Advanced Accelerator Applications.
- Canonical profile: https://brandsource.ai/brands/advanced-accelerator-applications
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/advanced-accelerator-applications/json-ld
- Citation profile API: https://brandsource.ai/api/brands/advanced-accelerator-applications/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (78/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-22
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
At Advanced Accelerator Applications, we are reimagining nuclear medicine and cancer care. Our mission is to transform patients’ lives by developing and delivering targeted radioligand therapies and precision diagnostic solutions for oncology.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 1 supporting source linked.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.